Achieve Life Sciences (STU:SP4P) OCF Yield %: -7.22 (As of Jul. 11, 2026)


STU:SP4P Achieve Life Sciences Inc STU:SP4P
32 GF Score
Price €5.35
! 4 Warning Signs
View Full Analysis

What is Achieve Life Sciences OCF Yield %?

Achieve Life Sciences STU:SP4P -3.60% 32 OCF Yield % is -7.22 as of Jul. 11, 2026. GuruFocus rates STU:SP4P with a GF Score™ of 32/100. The stock has 4 warning signs investors should review. Among 1,409 Biotechnology companies, Achieve Life Sciences ranks better than 52.87% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Achieve Life Sciences's Trailing 12-Month Cash Flow from Operations is €-38.87 Mil, and Market Cap is €550.80 Mil. Therefore, Achieve Life Sciences's OCF Yield % for today is -7.22%.

The historical rank and industry rank for Achieve Life Sciences's OCF Yield % or its related term are showing as below:

STU:SP4P' s OCF Yield % Range Over the Past 10 Years
Min: -277.96   Med: 5923.84   Max: 23754.89
Current: -7.22


During the past 13 years, the highest OCF Yield % of Achieve Life Sciences was 23754.89%. The lowest was -277.96%. And the median was 5923.84%.

STU:SP4P's OCF Yield % is ranked better than
52.87% of 1409 companies
in the Biotechnology industry
Industry Median: -8.05 vs STU:SP4P: -7.22

Achieve Life Sciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Achieve Life Sciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Achieve Life Sciences OCF Yield % Related Terms


Achieve Life Sciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Achieve Life Sciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Achieve Life Sciences OCF Yield % Chart

Achieve Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.73 -85.71 -29.30 -24.14 -21.74

Achieve Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -48.47 -35.21 -29.02 -31.60 -17.98

STU:SP4P vs STTK, CRMD, EIKN: OCF Yield % Comparison

For the Biotechnology subindustry, Achieve Life Sciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Achieve Life Sciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's OCF Yield % falls into.


STU:SP4P
32GF Score
Achieve Life Sciences Inc STU:SP4P
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Achieve Life Sciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Achieve Life Sciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-42.243 / 194.3041
=-21.74%

Achieve Life Sciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-5.996 * 4 / 133.368705
=-17.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -7.22 mean?
Achieve Life Sciences (STU:SP4P) has a OCF Yield % of -7.22 as of Jul. 11, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Achieve Life Sciences and its competitors. According to the industry distribution chart, Achieve Life Sciences ranks #664 out of 1409 companies in the Biotechnology industry, placing it in the top 47.1%.
Is Achieve Life Sciences' OCF Yield % too high?
Achieve Life Sciences' current OCF Yield % is -7.22. Based on the distribution chart, Achieve Life Sciences ranks #664 out of 1409 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Achieve Life Sciences has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Achieve Life Sciences' OCF Yield % compare to STTK and CRMD?
According to the Biotechnology industry distribution chart, Achieve Life Sciences ranks #664 out of 1409 companies for OCF Yield %. This puts Achieve Life Sciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Achieve Life Sciences and its competitors. Achieve Life Sciences's current OCF Yield % is -7.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Achieve Life Sciences stock overvalued right now?
Achieve Life Sciences (STU:SP4P) has a current OCF Yield % of -7.22. The current OCF Yield % is -7.22. Achieve Life Sciences' overall GF Score™ is 32/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Achieve Life Sciences (STU:SP4P), the current OCF Yield % is -7.22 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Achieve Life Sciences Business Description

Other Exchanges ACHV:USASP4P:Germany
Address 22722 29th Drive SE, Suite 100, Bothell, WA, USA, 98021
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
32GF Score

Get the complete analysis for STU:SP4P

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.35
Price